Compare Humana Inc (HUM) vs PepsiCo, Inc. (PEP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs PepsiCo, Inc. — how do they compare? Humana Inc trades at $373.38 (market cap $46.31B), while PepsiCo, Inc. trades at $138.32 (market cap $187.99B). The key difference: PepsiCo, Inc. is far larger — about 4.1× Humana Inc's market cap, and PepsiCo, Inc. pays the higher dividend (4.3%). Which is the better fit depends on your goals.
| HUM | PEP | |
|---|---|---|
Market Cap | $46.31B | $187.99B |
Sector | Health | Consumer Staples |
52-Week High | $409.42 | $170.44 |
52-Week Low | $163.67 | $134.95 |
Enterprise Value | $53.67B | $230.48B |
Dividend Yield | 0.92% | 4.3% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
PepsiCo (PEP) trades at $138.41, down 0.44% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported revenue of $93.93B in 2025 and has beaten EPS estimates for the last three quarters. Recent news highlights price cuts on snacks like Doritos to address consumer pushback on high prices, while analysts anticipate in-line Q1 2026 results.
The outlook is mixed: strong profitability and a 33% analyst buy rating support upside to the $158.79 consensus target, but near-term risks include competitive pressures and execution of the North America turnaround. The stock offers a solid dividend, but investors face volatility from sentiment shifts and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →
